Stem Cell Therapy to Redefine Regenerative Medicine, says …

Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact pressreleases@worldnow.com.

SOURCE Frost & Sullivan

SINGAPORE, July 28, 2015 /PRNewswire/ --Faced with increasing challenges such as costly treatments and treatments that are palliative rather than symptomatic, the global healthcare industry today is gradually transforming itself. With few existing therapies capable of curing or significantly changing the course of a disease, healthcare providers are starting to look towards regenerative medicine as a viable alternative.

Regenerative medicine represents a new paradigm in human health with the potential to resolve unmet medical needs by addressing the underlying causes of diseases.

According to Dr. Jane Andrews, Senior Consultant, Healthcare & Life Sciences, Frost & Sullivan, regenerative medicine has the potential to cure diseases like we have never seen before. Because of this, the market, especially in the area of stem cell therapy, will continue to experience positive growth, boosted by support from other sectors.

"Regenerative Medicine initiatives are now attracting new public and private funding. Although Stem Cell Therapy will continue to be the largest market segment of Regenerative Medicine, cross segment therapies that combine the use of immunology, genetic and stem cell therapy are rapidly advancing," Andrews noted.

Regenerative medicine has also been an area of interest for major pharma companies, many of which have set up their own R & D units or have acquired stakes / invested in regenerative medicine companies. Major pharmaceutical companies which have done so include Pfizer, Johnson & Johnson and Teva Pharma.

Why Stem Cell Therapy?

In this space, cell therapy is the fastest growing segment of regenerative medicine and also the largest. Globally, the stem cell therapy market is expected to be worth US $40 billion by 2020 and US $180 billion by 2030.

Cell therapy involves the use of living cells to replace or augment damaged or diseased cells and tissues. It has been used for various conditions. The largest number of marketed cell therapy products is used for the treatment of notably non-healing wounds / skin (46%) and muscular-skeletal injuries (35%). This trend will change as more and stem cell therapy products for cancer and heart disease complete their clinical trials and are approved for market release.

Continued here:
Stem Cell Therapy to Redefine Regenerative Medicine, says ...